Mark For: LUMAKRAS® trademark registration is intended to cover the categories of pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders. [all]
Status
2021-05-28 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Elsa D. Lemoine
Attorney Docket Number
TM-2089-US-1
Timeline
2020-07-09
Application Filed
2020-07-13
Location: NEW APPLICATION PROCESSING
2020-07-13
Status: Live/Pending
2020-07-13
Transaction Date
2020-09-29
Published
2020-11-24
Location: INTENT TO USE SECTION
2021-04-02
Status: A first request for extension of time to file a Statement of Use has been granted.
ELSA D. LEMOINE AMGEN INC. ONE AMGEN CENTER DRIVE TRADEMARK OPERATIONS-MS-28-5A THOUSAND OAKS, CA 91320-1799
Good, Services, and Codes
IC 005. US 005 006 018 044 046 051 052. G & S: pharmaceutical preparations for use in the treatment of cancer. FIRST USE: 20210603. FIRST USE IN COMMERCE: 20210603
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
Type Code
Type
GS0051
Pharmaceutical preparations; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
GS0051
pharmaceutical preparations for use in the treatment of cancer
Trademark Filing History
Description
Date
Proceeding Number
REGISTERED-PRINCIPAL REGISTER
2021-09-14
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2021-08-07
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2021-08-06
STATEMENT OF USE PROCESSING COMPLETE
2021-07-13
66230
CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-07-12
66230
USE AMENDMENT FILED
2021-06-30
66230
TEAS STATEMENT OF USE RECEIVED
2021-06-30
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-04-06
TEAS EXTENSION RECEIVED
2021-04-02
SOU EXTENSION 1 GRANTED
2021-04-02
98765
SOU EXTENSION 1 FILED
2021-04-02
98765
EXTENSION 1 GRANTED
2021-04-02
98765
EXTENSION 1 FILED
2021-04-02
98765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-11-24
PUBLISHED FOR OPPOSITION
2020-09-29
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-09-29
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-09-09
APPROVED FOR PUB - PRINCIPAL REGISTER
2020-08-21
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2020-08-20
6328
EXAMINERS AMENDMENT E-MAILED
2020-08-20
6328
EXAMINERS AMENDMENT -WRITTEN
2020-08-20
94491
EXAMINER'S AMENDMENT ENTERED
2020-08-20
88888
ASSIGNED TO EXAMINER
2020-08-17
94491
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.